Get Permission Saha, Hassan, Nur, Shahjahan, and Lutfor: Etiological study of blood stream infection in a maternal and child healthcare based tertiary hospital


Introduction

Bloodstream infection (BSI) due to bacterial pathogens constitutes one of the most critical situations among infectious diseases. Continuous, intermittent, or transient presence of microorganisms in circulating blood is a threat to every organ in the body. It is often associated with increased length of hospital stay, a significant amount of healthcare related costs and most significantly, a high rate of morbidity and mortality.1 The mortality rate for BSI varies between 4.0 and 41.5%2, 3, 4, 5, 6, 7 depending on the age, severity of infection and other risk factors. Current studies have reported a rapid increase in the number of bloodstream infections from both community and nosocomial sources.8, 9 Bloodstream infection is one of the major causes of neonatal mortality in developing countries. In some communities almost half of patients in neonatal intensive care units acquire infection.10, 11 The World Health Organization has estimated that 10 millions of neonates die during the first five days after birth. It is reported that one in five neonates in some developing countries is suffering from septicemia.12 Neonatal blood stream infection can be acquired vertically from birth canal or environmentally due to lack of health facilities.

Prevalence and antimicrobial susceptibility of microorganism varies depending upon the geographic location, age, co-morbid illnesses and the use of antibiotics. The epidemiology and pathogen profile of BSIs changes in different regions.13 So, constant analysis of local trends is required. The final outcome of disease might be much improved by available epidemiologic data for the most frequently isolated pathogenic organisms and their susceptibility to antimicrobial agents. Making of proper empirical treatment choices can also be achieved by understanding local epidemiological studies. This is especially true for Bangladesh and other developing countries where healthcare systems operate on poor hygiene system and there is gap in the facilities or policies of infection prevention and control (IPC) strategies to contain infections. The excessive and irrational use of antibiotics has led to an increase in the multidrug-resistant bugs and thus worsened the condition. Bloodstream infections have serious consequences like shock, disseminated intravascular coagulation, multiple organ failure, and even death. Increased hospital stay and associated costs are the most troublesome consequences.14 The application of hospital-wide antibiograms to guide clinicians in the initial choice of antimicrobials is the usual approach adopted.

In this study, we aimed to identify the most prevalent bacterial pathogens involved in BSI in a maternal and child health care based hospital in Dhaka, Bangladesh according to age group. We also determined antibiotic susceptibility patterns of the pathogens to see the changing trend of antimicrobial susceptibility in this region.

Materials and Methods

In this retrospective study, blood samples were obtained from patients attending out-patient and in-patient departments at Ad-din Women’s Medical College & Hospital, Dhaka, Bangladesh, which is famous for maternal and child health care services. A total of 6095 blood samples were processed from July 2019 to December 2020. All the blood samples were processed for culture using a BACT/Alert blood culture machine to identify the presence of bacterial pathogens. Manual method has been utilized as well. Antimicrobial susceptibility tests were performed on the isolated pathogens using Kirby-Bauer disk diffusion method.

Bacterial isolation

Collected blood samples were directly inoculated into adult (more than 12 years of age) and pediatric (up to 12 years of age) FAN blood culture bottle. Bottles were incubated in the BACT/Alert machine for up to 5 days. One drop of blood from growth positive culture bottles were directly inoculated onto MacConkey (MC) agar and blood agar (5% sheep blood) plates. MacConkey plates were then incubated at 37 °C in aerobic condition. Blood agar plates were incubated at 35 °C in aerobic condition. The bacterial isolates were identified and confirmed by using standard microbiological and biochemical tests like Gram staining, growth on selective media, colony morphology on culture media, lactose fermentation, indole, and citrate utilization, H2S production, catalase, coagulase, oxidase, and urease test according to guidelines of World Health Organization.15

Antimicrobial susceptibility testing

Antimicrobial susceptibility testing was performed on Mueller Hinton agar (Merck, Germany) using disc diffusion (Kirby-Bauer’s) technique according to Clinical and Laboratory Standards Institute (CLSI) guidelines of 2015.16 The antibiotic discs of ampicillin (Amp), cephradine (Ceph), cotrimoxazole (Cot), ciprofloxacin (Cip), levofloxacin (Lev), nalidixic acid (NA), ceftriaxone (CTR), chloramphenicol (Clo), amoxiclav (AMC), cefixime (CXM), cefotaxime (CTX), gentamicin (Gen), amikacin (AK), azithromycin (Az),ceftazidime (CAZ), meropenem (Mero), piperacillin-tazobactam (PIT), colistin (Col) were used for Gram negative bacteria and ampicillin (Amp), cephradine (Ceph), cotrimoxazole (Cot), ciprofloxacin (Cip), levofloxacin (Lev), cefotaxime (CTX), ceftriaxone (CTR), amoxiclav (AMC), gentamicin (Gen), amikacin (AK), imepenem (Ime), cefixime (CXM), oxacillin (Ox), cloxacillin (Clox), erythromycin (Ery), doxycycline (Do), vancomycin (Van), linezolid (Lz) were used for Gram positive bacteria. All antibiotic discs are obtained from Oxoid Ltd, Bashingstore, Hampire, UK.

Statistical analysis and ethical approval

Statistical analysis was performed by using the SPSS software (version 25, IBM). Differences between proportions were compared using Chi square test with cut off for statistical significance at p = 0.05 and 95% confidence interval. Qualitative values were expressed as percentages.

Ethical statements

The research protocol was approved by Institutional Review Board (IRB) of Ad- din Women’s Medical College & Hospital, code no AWMC IRB/21 July 2021/027.

Result

A total of 6095 blood culture samples were taken from patients, of them majority were female (3819 Female, 2276 Male) with male female ratio M: F=.1.5: 1. Distribution of the patient’s sample according to age group was illustrated in Table 1. Almost 30% (1824/6095) of the sample were received from neonatal intensive care unit (NICU), 8% (492/6095) percent patients were aged between 1 months -1 year & 43.6% (2658/6095) from children (aged from 1 to 5 years), 18.4% (1121/6095) from adults (age >15 years) (Table 1). Pathogenic microbes were isolated from 10.6% (648/6095) of the blood cultures (Table 1).

Blood stream infection rate is highest among neonates (48.3%, 313/648), followed by, the age group of 1-15 Year (32.7%, 202/648), Adult patients (11.4%, 74/648) and the age group of 1 month- 1 Year (7.6%, 49/648) (Figure 1).

Figure 1

Distribution of growth positive cases by age group

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/d14f8c4e-ac85-4cda-b61b-e6f86c605a8d/image/0ea3964c-9789-4b57-9a4e-5c3a7c4b8fa0-uimage.png

Among the growth positive cases, 64.2% (416/648) were infected by Gram negative bacilli while 35.8% (232/648) cases were infected by Gram positive cocci (Table 2). S.Typhi was the predominant isolates 207 (32%), followed by Coagulase negative Staphylococci (CONS) 194 (30%), Acinetobacter 98 (15.1%), S. paratyphae 36 (5.6%), Staphylococcus aureus 31 (4.8%) & Klebsiella spp. (3.9%). Few Enterobacter, Proteus, Pseudomonas, Enterococci species were also isolated.

The most frequently isolated pathogens in NICU were Coagulase Negative Staphylococci Spp (n =194), and Acinetobacter Spp (n=98); whereas, Salmonella Typhi was most commonly isolated pathogen among pediatrics and adult age group (n=207) [p=<.001]. These findings suggest that Coagulase negative Staphylococci Spp. and Acinetobacter Spp. are significantly associated with neonatal blood stream infection whereas, Salmonella Typhi is significantly associated with blood stream infection in childhood and adult patients (Table 2).

The rates of susceptibility to selected antimicrobial agents against Gram positive cocci and Gram negative bacilli are demonstrated in Table 4 respectively.

In this study, S. Typhi isolates, the predominant cause of BSI, showed higher sensitivity to meropenem (87%), cefixime (77.3%), amikacin (74.4%), doxycycline & azithromycine (71.5%), ceftriaxone (67.1%). Almost 30% (29.8%, 61/207) of the isolates are identified as MDR (Multidrug resistant = Resistant to ampicillin, cotrimoxazole and Chloramphenicol).

Staphylococci were responsible for majority of Neonatal blood stream infection cases; among these, CONS isolates were most frequently isolated. They showed high resistance to cephradin, nalidixic acid, erythromycin, and high sensitivity to, imepenem, vancomycin and linezolid (Table 4). Staphylococcus aureus is the second commonest Gram positive organism responsible for BSI.

Acinetobacter spp. is the second commonest pathogens in neonatal blood stream infection. They showed higher sensitivity to colistin (98%), meropenem (97%), piperacillin- tazobactum (80%), & amikacin (77.8%).

E. coli showed higher sensitivity to meropenem (95.2%), piperacillin- tazobactum (95.2%), amikacin (76%), gentamycin (76%) and high resistance to ampicillin, cephradin, chloramphenicol. Other Enterobacterieceae like Klebsiella, Enterobacter, Proteus has showed similar Sensitivity pattern.

Table 1

Distribution of patients with blood stream infection patients byage groups

Sample received

Neonate (<1 month) N (%)

1moth -1year N (%)

1 year-15 year N (%)

Adult (>15 years) N (%)

Total N (%)

Growth Positive

332 (18.2)

49 (10)

202 (8.2)

65 (5.8)

648(10.6)

Growth Negative

1492(81.8)

443(90)

2456(91.8)

1056(94.2)

5447(89.4)

Total

1824(100)

492(100)

2658 (100)

1121 (100)

6095(100)

Table 2

Frequency of bacterial pathogens causing bloodstream infection by age groups

Pathogen

Neonate (<1 month)

1moth -1 year

1 year-15 year

Adult (>15 years)

Total N=648(100%) N (%)

P Value

Gram negative isolates

<.001*

S. Typhi

0

5

148

54

207 (32%)

Acinetobacter

75

9

14

98(15.1%)

E.coli

5

1

4

4

14(2.2%)

S.paratyphae

0

4

19

13

36(5.6%)

Klebsiella

17

1

5

2

25(3.9%)

Enterobacter

18

3

21(3.2%)

Proteus

5

2

2

9(1.4%)

Pseudomonas

4

1

1

6(0.1%)

Total Gram negatives

124

23

196

73

416(64.2%)

Gram positive isolates

CONS

165

19

9

1

194(30%)

Staphylococcus aureus

19

5

7

31(4.8%)

S.pneumonie

3

1

0

0

4 0(.06%)

Enterococci

2

1

0

0

3(0.05%)

Total Gram positives

189

26

16

1

232(35.8%)

[i] [N.B: The p value was calculated between Age group 1 day - 1 year and >1 year. For statistical analysis we have merged neonate and infant in one group & children and adults in one group. *means statistically significant.]

Table 3

Susceptibility pattern ofgram positive organisms causing blood stream infection

Antibiotics

CONS N=(194)

S. aureus N=(31)

Enterococci (4)

S.pneumoniae (3)

S (%)

S (%)

S (%)

S (%)

Ampicillin

20(10.31)

3(9.68)

1(25)

0(0)

Cotrimoxazole

109(56.19)

17(54.84)

2(50)

1(33.33)

Ciprofloxacine

89(45.88)

19(61.29)

2(50)

1(33.33)

Doxycycline

116(59.79)

21(67.74)

3(75)

2(66.67)

Cefepime

108(55.67)

17(54.84)

2(50)

1(33.33)

Levofloxacine

96(49.48)

20(64.52)

2(50)

1(33.33)

Ceftriaxone

112(57.73)

16(51.61)

2(50)

1(33.33)

Cefotaxime

89(45.88)

15(48.39)

2(50)

1(33.33)

Amoxyclav

119(61.34)

18(58.06)

2(50)

2(66.67)

Oxacillin

51(26.29)

9(29.03)

1(25)

1(33.33)

Cloxacillin

48(24.74)

10(32.26)

2(50)

1(33.33)

Cefixime

62(31.96)

17(54.84)

3(75)

2(66.67)

Erythromycin

98(50.52)

14(45.16)

2(50)

2(66.67)

Amikacin

138(71.13)

24(77.42)

3(75)

2(66.67)

Imepenem

159(81.96)

26(83.87)

3(75)

3(100)

Gentamicin

138(71.13)

21(67.74)

3(75)

2(66.67)

Vancomycin

173(89.18)

28(90.32)

4(100)

3(100)

Linezolid

194(100)

31(100)

4(100)

3(100)

Table 4

Susceptibility pattern ofgram negative organisms isolated from Blood stream infection

Antibiotics

S. Typhi (N=207)

Acinetobacter (N=98)

S.paratyphi (N=36)

Klebsiella (N=25)

Enterobacter (N=21)

Proteus (N=9)

Pseudomonas (N=6)

E.coli (N=14 )

S(%)

S(%)

S(%)

S(%)

S(%)

S(%)

S(%)

S(%)

Ampicillin

46(22.2)

11(11.2)

3(8.3)

2(8)

2(9.5)

1(11.1)

(0)

3(21.4)

Cephradine

63(30.4)

19(19.4)

8(22.2)

3(12)

3(14.3)

1(11.1)

(0)

4(28.6)

Cotrimoxazole

103(49.8)

48(49)

16(44.4)

13(52)

12(57.1)

4(44.4)

4(66.7)

9(64.3)

Ciprofloxacin

107(51.7)

47(48)

18(50)

12(48)

11(52.4)

4(44.4)

3(50)

8(57.1)

Levofloxacin

110(53.1)

50(51)

18(50)

13(52)

12(57.1)

5(55.6)

3(50)

9(64.3)

Nalidixic acid

98(47.3)

44(44.9)

15(41.7)

12(48)

10(47.6)

4(44.4)

2(33.3)

8(57.1)

Ceftriaxone

139(67.1)

45(45.9)

20(55.6)

13(52)

12(57.1)

5(55.6)

4(66.7)

10(71.4)

Cefotaxime

108(52.2)

43(43.9)

14(38.9)

11(44)

11(52.4)

4(44.4)

2(33.3)

8(57.1)

Amoxyclav

124(59.9)

13(13.3)

17(47.2)

12(48)

12(57.1)

5(55.6)

3(50)

9(64.3)

Chloramphenicol

143(69.1)

36(36.7)

21(58.3)

6(24)

5(23.8)

4(44.4)

(0)

6(42.9)

Cefuroxime

113(54.6)

8(8.2)

16(44.4)

13(52)

13(61.9)

5(55.6)

(0)

8(57.1)

Amikacin

154(74.4)

62(63.3)

28(77.8)

19(76)

17(81)

7(77.8)

5(83.3)

12(85.7)

Meropenem

180(87)

73(74.5)

35(97.2)

22(88)

20(95.2)

8(88.9)

6(100)

13(92.9)

Gentamicin

118(57)

53(54.1)

21(58.3)

16(64)

16(76.2)

6(66.7)

4(66.7)

10(71.4)

Ceftazidime

120(58)

47(48)

16(44.4)

12(48)

12(57.1)

4(44.4)

2(33.3)

8(57.1)

Azithromycin

148(71.5)

NU

22(61.1)

(0)

(0)

(0)

3(50)

(0)

PiperacillinTazobactam

NU

79(80.6)

33(91.7)

24(96)

20(95.2)

8(88.9)

5(83.3)

14(100)

Colistin

NU

96(98)

(0)

25(100)

21(100)

9(100)

6(100)

14(100)

Cefixime

160(77.3)

43(43.9)

30(83.3)

13(52)

14(66.7)

5(55.6)

4(66.7)

8(57.1)

Doxycycline

148(71.5)

45(45.9)

19(52.8)

13(52)

9(42.9)

4(44.4)

(0)

7(50)

[i] NU= Not Used

Discussion

The complications related to blood stream infections and the rising resistances against commonly used antimicrobial agents are the compelling matters of the world now. In the present study most of the samples were collected from (Table 1) children and neonates (43.6%, 30%) and most patients were female.

The overall blood stream infection rate in this study was found to be 10.6% (Table 1) and anaerobic culture was not done. The predominance of BSI (Figure 1) is observed among neonates (48.3%) than other age groups which in accordance with another study17 where they found 54% neonatal isolates. One of the reasons behind the fact that 30% of the samples were received from NICU; as our NICU is one of the referral centers for neonate from different hospitals of Bangladesh.

Patients admitted to ICUs have a higher risk of nosocomial BSIs than those admitted to other units. Neonates are more vulnerable to infection as they can acquire infection vertically from dealing with both prematurity and low birth weight is increasing.18, 19, 20

Salmonella Typhi was the predominant isolates, 207 (32%) in total blood samples and also isolated maximum (148) from the 1-15 years age group (Table 2). Similar finding was observed in couple of studies21, 22 who had found S. Typhi as predominant Gram negative organism and CONS as predominant Gram positive organism.

Several studies from Bangladesh have already identified S. Typhi as a common cause of blood stream infection in this region.23, 24, 25

S. Typhi, the causative agent of typhoid fever, is a major public health concern in Bangladesh and other developing Asian countries. Salmonella species was responsible for almost half of the disease burden associated with BSI in Dhaka, Bangladesh in past decades and about 80% of these infections were due to S. Typhi; but an overall decrease in Salmonella species isolation rate over the recent years21 has been observed. This decrease may be attributed to the improved urban water management system and sanitation practices in Dhaka city over the past years and vaccination against S. Typhi.

The most frequently isolated pathogens among neonates were Coagulase negative Staphylococci Spp (52.7%, 165 /313) and Acinetobacter Spp (24%, 75 /313) in this study (Table 2).

Within the first week of life, neonates become rapidly colonized by environmental pathogen.26, 27 The risk of BSI is substantially increasing with CONS & Acinetobacter infection with the use of central venous catheters (CVC), mechanical ventilation, and parenteral nutrition, and with exposure to other invasive skin or mucosa-breaching procedures.28, 29 Consequently, infants admitted to a hospital obtain most of their microorganisms from the hospital environment, their parents, and staff.30 Transmission via the hands of hospital staff can lead to endemic strains circulating for extended periods.31 Antibiotic resistance in skin-residing strains has been found to be low at birth but it increases rapidly during the first week of hospitalization. The spectrum and antibiotic resistance pattern of microorganisms isolated from neonates depends on the selective pressure as a result of perinatal antibiotic exposure.32

CONS & Acinetobacter spp. blood infection can occur in the babies without being under intensive care or antibiotics, mechanical ventilation or having indwelling catheters.3

S. Typhi isolates, the predominant cause of BSI in older age group, showed higher sensitivity to meropenem (87%), cefixime (77.3%), amikacin (74.4%), doxycycline, azithromycin (71.5%) & ceftriaxone (67.1%). By mid-1990s, about half of the S. Typhi strains were MDR; these were resistant against three first line antibiotics - ampicillin, cotrimoxazole and chloramphenicol.33 A decline in the percentage of MDR S. Typhi strains from 61.7 to 23.7% within 2005- 2014 has been observed in our country.17 As indicated by recent studies from Bangladesh, S. Typhi still shows a high level of resistance against first line antibiotics.23 In our study (Table 2), almost 30% (29.8%) of the isolates are identified as MDR (Multidrug resistant where Resistant to ampicillin, cotrimoxazole and chloramphenicol). These findings are concordant with other reports from our countries and neighboring countries like India & Nepal.21, 34, 35

However, we have observed a remarkable increase of susceptibility against chloramphenicol (69.1%) in this study. Cotrimoxazole sensitivity is also increased (50%) than the studies of previous decades 21. Hopefully, if this trend continues, cheaper first line antibiotics to treat S. Typhi infections might be possible in near future.

Staphylococci spp., the major pathogen of neonatal BSI in this study, was ascertained with high resistance to cephradine, erythromycin, and high sensitivity to, imepenem, vancomycin and linezolid. Staphylococcus aureus remains as second most common Gram positive organism. Both vancomycin and linezolid are good treatment of choice against CONS and S. aureus which are usually resistant to commonly used antibiotics.

Acinetobacter spp. is the second commonest pathogens in neonatal blood stream infection. We have observed higher sensitivity (table) to colistin (98%), meropenem (97%), piperacillin- tazobactum (80%), & amikacin (77.8%).

In previous decades Acinetobacter remained as the most common isolate of Neonatal BSI in Bangladesh, but Coagulase-negative staphylococci (CONS) are found to be the most commonly isolated pathogens in the neonatal intensive care unit (NICU) in some other countries 36. They are the major pathogen involved in Late Onset Neonatal Sepsis (LONS), particularly in infants born at a lower gestational age.

E.coli showed higher sensitivity to meropenem (92%), piperacillin- tazobactum (100%), amikacin (85.7%), and gentamycin (76%). So, carbapenems may be considered as a good choice of treatment for BSI caused by E. coli. Klebsiella species as it is showed the highest level of resistance against β-lactams, especially penicillins and third generation cephalosporins.

Limitation of the Study

Due to the lack of resources, we were not able to differentiate the samples received from indoor and outdoor patients. As a result, we could not show the difference between nosocomial and community acquired BSI. We were also not able to collect patient data on the clinical manifestations or any other patient characteristics, other than age and sex, which could be considered as risk factors for BSI. Also, we were not able to perform any molecular tests on received samples due to lack of required resources and adequate fund.

Conclusion

Major bacterial pathogens involved with bloodstream infections (BSI) occurring in Dhaka city among different age groups of patients and their antibiotic susceptibility patterns are demonstrated in our study. In a nutshell our study reveals that, Blood stream infection is higher amongst neonates. CONS are predominant pathogen for neonates and S. Typhi is predominant for 1-15 years age group children. Among 30% S. Typhi strains were found to be MDR. High resistance to cephradine, erythromycin, and high sensitivity to imepenem, vancomycin and linezolid were found among CONS strains. We hope that, our findings will help healthcare professionals to provide better care for their patients & also help the researchers and policy makers to make appropriate antibiotic policy to face future challenges of infectious diseases.

Source of Funding

This study was not funded.

Declaration of Interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.

Acknowledgements

We are very grateful to Mr. Anwar Hossain, Chief Lab. Technician and the staffs of Microbiology Department, Laboratory Division, AWMCH.

References

1 

M Tumbarello T Spanu RD Bidino M Marchetti M Ruggeri EM Trecarichi Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapyAntimicrob Agents Chemother20105410408591

2 

M Kanoksil A Jatapai SJ Peacock D Limmathurotsakul Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance studyPLoS One201381e54714

3 

MH Kollef MD Zilberberg AF Shorr L Vo J Schein ST Micek Epidemiology, microbiology and outcomes of healthcare associated and community-acquired bacteremia: a multicenter cohort studyJ Infect20116221305

4 

J Cohen J L Vincent Nkj Adhikari Sepsis: a roadmap for future researchLancet Infect Dis201515581614

5 

Geneva Misdiagnosed ‘sepsis’ now a global health priority for World Health Organization2017https://www.global-sepsis-alliance.org/s/WHA-Adopts-Resolution-on-Sepsis.pdf.Accessed

6 

J Valles Evolution over a 15-year period of clinical characteristics and outcomes of critically ill patients with community-acquired bacteremiaCrit Care Med20134117683

7 

United Nations Inter-agency Group for Child Mortality Estimation (UN IGME). Levels & trends in child mortality: report 2019, estimates developed by the United Nations Inter-agency Group for Child Mortality EstimationUnited Nations Children’s Fund2019New York, NY

8 

N D Friedman Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infectionsAnn Intern Med200213710791798

9 

H F Leal J Azevedo G E Silva A M Amorim L R De Roma A C Arraes E L Gouveia M G Reis A V Mendes M De Oliveira Silva M G Barberino Bloodstream infections caused by multidrug-resistant gram-negative bacteria: epidemiological, clinical and microbiological features. BMC infectious diseases20191911

10 

N Modi C J Doré A Saraswatula M Richards K B Bamford R Coello A case definition for national and international neonatal bloodstream infection surveillanceArch Dis Child Fetal Neonatal Ed2009941812

11 

J Johnson M L Robinson U C Rajput C Valvi A Kinikar T B Parikh U Vaidya S Malwade S Agarkhedkar B Randive A Kadam High burden of bloodstream infections associated with antimicrobial resistance and mortality in the neonatal intensive care unit in PuneClinical Infectious Diseases202173227180

12 

T Elster M Beataczeszyńska D Sochaczewska H Konefał E Baryła-Pankiewicz Analysis of risk factors for nosocomial infections in the Neonatal Intensive Care Unit of the Pomeranian Medical University in Szczecin in the yearsGinekol Pol2005808609623

13 

Southeast Asia Infectious Disease Clinical Research Network. Causes and outcomes of sepsis in Southeast Asia: A multinational multicentre cross-sectional studyLancet Glob Health2017515767

14 

L Jin C Zhao H Li R Wang Q Wang H Wang Clinical Profile, Prognostic Factors, and Outcome Prediction in Hospitalized Patients with Bloodstream Infection: Results From a 10-Year Prospective Multicenter StudyFront Med (Lausanne)20218629671

15 

J Vandepitte Basic laboratory procedures in clinical bacteriologyWorld Health Organization2003

16 

JB Patel FR Cockerill PA Bradford Performance standards for antimicrobial susceptibility testing: twenty-fifth informational supplementClinical and Laboratory Standards Institute2015352950

17 

A Onken AK Said M Jørstad PA Jenum B Blomberg Prevalence and antimicrobial resistance of microbes causing bloodstream infections in Unguja, ZanzibarPloS One20151012e0145632

18 

M Stocker M Fontana S EiHelou S Wegscheider TM Berger Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trialNeonatology201097216574

19 

Y Xu LJ Zhang HY Ge DH Wang Clinical analysis of nosocomial infection in neonatal intensive care unitsZhonghua Er Ke Za Zhi200745643741

20 

A Holmes CJ Doré A Saraswatula KB Bamford MS Richards R Coello Risk factors and recommendations for rate stratification for surveillance of neonatal healthcare-associated bloodstream infectionJ Hosp Infect20086816672

21 

D Ahmed MA Nahid AB Sami F Halim N Akter T Sadique Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005–2014Antimicrob Resist Infect Control2005611Dhaka, Bangladesh

22 

N Vasudeva PS Nirwan P Shrivastava Bloodstream infections and antimicrobial sensitivity patterns in a tertiary care hospital of IndiaTher Adv Infect Dis20163511927

23 

WA Brooks Bacteremic typhoid fever in children in an urban slumEmerg Infect Dis20051123269

24 

A Naheed PK Ram WA Brooks MA Hossain MB Parsons KA Talukder Burden of typhoid and paratyphoid fever in a densely populated urban community, Dhaka, BangladeshInt J Infect Dis2010143939

25 

SK Saha AH Baqui M Hanif GL Darmstadt M Ruhulamin T Nagatake Typhoid fever in Bangladesh: implications for vaccination policyPediatr Infect Dis J20012055214

26 

MT Brady Health care-associated infections in the neonatal intensive care unitAm J Infect Control200533526875

27 

DA Goldmann Bacterial colonization and infection in the neonateAm J Med198170241722

28 

PL Graham MD Begg E Larson P Della-Latta A Allen L Saiman Risk factors for late onset gram-negative sepsis in low birth weight infants hospitalized in the neonatal intensive care unitPediatr Infect Dis J20062521137

29 

I Adams-Chapman BJ Stoll Prevention of nosocomial infections in the neonatal intensive care unitCurr Opin Pediatr200214215764

30 

J Huebner DA Goldmann Coagulase-negative staphylococci: role as pathogensAnnu Rev Med19995022336

31 

CH Patrick JF John AH Levkoff LM Atkins Relatedness of strains of methicillin-resistant coagulase-negative Staphylococcus colonizing hospital personnel and producing bacteremias in a neonatal intensive care unitPediatr Infect Dis J1992111193540

32 

V Hira RF Kornelisse M Sluijter A Kamerbeek WHF Goessens R Groot Colonization dynamics of antibiotic-resistant coagulase-negative Staphylococci in neonatesJ Clin Microbiol20135125957

33 

A Mishra S Mishra G Jaganath RK Mittal PK Gupta DP Patra Acinetobacter Sepsis in NewbornsIndian Pediatr19983512732

34 

K Nagshetty ST Channappa SM Gaddad Antimicrobial susceptibility of Salmonella typhi in India J Infect Dev Ctries201042703

35 

B Khanal SK Sharma SK Bhattacharya NR Bhattarai M Deb R Kanungo Antimicrobial susceptibility patterns of Salmonella enterica serotype typhi in eastern NepalJ Health Popul Nutr2007251827

36 

N Jean-Baptiste DK Benjamin M Cohen-Wolkowiez VG Fowler M Laughon RH Clark Coagulase-negative staphylococcal infections in the neonatal intensive care unitInfect Control Hosp Epidemiol201132767986



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 20-06-2023

Accepted : 04-07-2023


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijmr.2023.011


Article Metrics






Article Access statistics

Viewed: 863

PDF Downloaded: 292